Channels: Optometry | Posted 7/28/2017
William Trattler, MD, discusses how corneal collagen cross-linking (CXL) can do more than just address keratoconus. Dr. Trattler shares the case of a 34-year-old man whose visual acuity improved from 20/40 to 20/20 following CXL. Dr. Trattler also reviews reasons why a patient may require a second CXL treatment.
Corneal Collagen Crosslinking, CXL